222 related articles for article (PubMed ID: 30309390)
1. Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses.
Dennis SJ; O'Kennedy MM; Rutkowska D; Tsekoa T; Lourens CW; Hitzeroth II; Meyers AE; Rybicki EP
Vet Res; 2018 Oct; 49(1):105. PubMed ID: 30309390
[TBL] [Abstract][Full Text] [Related]
2. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
4. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
5. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
[TBL] [Abstract][Full Text] [Related]
6. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.
Weyer CT; Grewar JD; Burger P; Joone C; Lourens C; MacLachlan NJ; Guthrie AJ
Vaccine; 2017 Apr; 35(18):2504-2510. PubMed ID: 28341113
[TBL] [Abstract][Full Text] [Related]
10. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
11. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
von Teichman BF; Dungu B; Smit TK
Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine.
Dennis SJ; Meyers AE; Guthrie AJ; Hitzeroth II; Rybicki EP
Plant Biotechnol J; 2018 Feb; 16(2):442-450. PubMed ID: 28650085
[TBL] [Abstract][Full Text] [Related]
13. Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design.
Calvo-Pinilla E; Marín-López A; Utrilla-Trigo S; Jiménez-Cabello L; Ortego J
Curr Opin Virol; 2020 Oct; 44():49-56. PubMed ID: 32659516
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.
Lulla V; Losada A; Lecollinet S; Kerviel A; Lilin T; Sailleau C; Beck C; Zientara S; Roy P
Vaccine; 2017 Jul; 35(33):4262-4269. PubMed ID: 28625521
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR
O'Kennedy MM; Coetzee P; Koekemoer O; du Plessis L; Lourens CW; Kwezi L; du Preez I; Mamputha S; Mokoena NB; Rutkowska DA; Verschoor JA; Lemmer Y
Vaccine; 2022 Aug; 40(35):5160-5169. PubMed ID: 35902279
[TBL] [Abstract][Full Text] [Related]
16. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.
Kanai Y; van Rijn PA; Maris-Veldhuis M; Kaname Y; Athmaram TN; Roy P
Vaccine; 2014 Sep; 32(39):4932-7. PubMed ID: 25045805
[TBL] [Abstract][Full Text] [Related]
18. African Horse Sickness: A Review of Current Understanding and Vaccine Development.
Dennis SJ; Meyers AE; Hitzeroth II; Rybicki EP
Viruses; 2019 Sep; 11(9):. PubMed ID: 31514299
[TBL] [Abstract][Full Text] [Related]
19. African horse sickness in The Gambia: circulation of a live-attenuated vaccine-derived strain.
Oura CA; Ivens PA; Bachanek-Bankowska K; Bin-Tarif A; Jallow DB; Sailleau C; Maan S; Mertens PC; Batten CA
Epidemiol Infect; 2012 Mar; 140(3):462-5. PubMed ID: 21733265
[TBL] [Abstract][Full Text] [Related]
20. Immune response of horses to inactivated African horse sickness vaccines.
Rodríguez M; Joseph S; Pfeffer M; Raghavan R; Wernery U
BMC Vet Res; 2020 Sep; 16(1):322. PubMed ID: 32873300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
